Correlation Engine 2.0
Clear Search sequence regions


  • 3 utr (2)
  • 4 and (1)
  • allele (7)
  • androgen (1)
  • blood (1)
  • brain (1)
  • chromatin (3)
  • comorbid (1)
  • cortisol (3)
  • CRH (6)
  • crh receptors (1)
  • CRHR1 (31)
  • CRHR2 (26)
  • decreases self- esteem (1)
  • distress (2)
  • factors (1)
  • falls (1)
  • gene (13)
  • genomes (1)
  • glucocorticoid (2)
  • hyperandrogenemia (1)
  • impaired (4)
  • insulin (8)
  • interest (1)
  • islet cells (1)
  • ligand (1)
  • mirna (1)
  • neurons (1)
  • oligomenorrhea (1)
  • ovaries (6)
  • pancreas (1)
  • pathogenesis (2)
  • patients (2)
  • phase (1)
  • regulates (2)
  • respond (1)
  • risk falls (1)
  • rs110402 (2)
  • rs171440 (1)
  • rs17689378 (1)
  • rs17689882 (1)
  • rs242941 (2)
  • rs56319902 (1)
  • rs62057097 (2)
  • rs62057144 (1)
  • rs7209436 (2)
  • rs7793837 (1)
  • rs80184151 (1)
  • self esteem (1)
  • serum (1)
  • skeletal muscle (1)
  • steroid (1)
  • steroid biosynthesis (2)
  • twin studies (1)
  • type 2 diabetes (12)
  • urocortin 3 (1)
  • women (6)
  • Sizes of these terms reflect their relevance to your search.

    Women with polycystic ovarian syndrome (PCOS) have increased hypothalamic–pituitary–adrenal (HPA) axis activation, pro-inflammatory mediators, and psychological distress in response to stressors. In women with PCOS, the corticotropin-releasing hormone (CRH) induces an exaggerated HPA response, possibly mediated by one of the CRH receptors (CRHR1 or CRHR2). Both CRHR1 and CRHR2 are implicated in insulin secretion, and variants in CRHR1 and CRHR2 genes may predispose to the mental-metabolic risk for PCOS.

    Citation

    Mutaz Amin, Nicholas Horst, Rongling Wu, Claudia Gragnoli. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome Journal of Ovarian Research. 2023 Aug 05;16


    PMID: 37543650

    View Full Text